Jennie Strobeck is AVP of State & Local Sales, Digital Media at Adobe, where she leads government sales strategy across city, county, and state agencies. With a career spanning enterprise tech sales at DLT Solutions, immixGroup, and Avaya Government Solutions, she has spent over two decades at the intersection of technology and public sector transformation. At Adobe, she previously served as Chief of Staff and Channel Sales Manager before stepping into the AVP role in 2022. She is particularly focused on digital accessibility, helping governments meet DOJ WCAG compliance requirements and modernize document workflows at scale.
Eric Free is the Chief Growth Officer at Flexera, the IT lifecycle management platform used by enterprises to govern software, cloud spend, and technology assets. With a career spanning Intel, Rovi Corporation, and now Flexera, Free has spent two decades driving growth at the intersection of enterprise software, IoT, and cloud strategy. At Flexera, he oversees corporate strategy, M&A, business development, and go-to-market operations — steering a company with $221M+ in annual revenue and $5.85B in total funding toward what it calls the 'value era' of cloud.
Kevin Yuann is the CEO of Peerspace, the leading marketplace for hourly venue rentals with over 45,000 unique spaces across seven countries. A veteran operator who spent a decade at NerdWallet - including as Chief Business Officer through a 15x revenue growth period and the company's 2021 IPO - Yuann brings a rare combination of consumer finance expertise and marketplace instincts to Peerspace. He holds a BA in Business Economics and Visual Arts from Brown University and an MBA from UCLA Anderson, and he took the helm at Peerspace in May 2024 as the platform crossed $500 million in total sales and one million bookings.
Steve Reardon is the CEO of Alpine Software Group (ASG), a Walnut Creek, California-based acquirer and operator of vertical SaaS businesses. Born in Durban, South Africa, he is an alumnus of the University of Cape Town and Stanford GSB's MSx Sloan Fellows program. Before leading ASG, Reardon founded multiple businesses including Peldon Technologies, ran South Africa's largest cycling retail chain, then pivoted to software M&A — overseeing 60+ acquisitions across legal tech, marketing tech, and other vertical software niches. Under his leadership, ASG has grown to ~160 employees and ~$25M in annual revenue, with a 65%+ growth rate and notable exits including Innovative Systems sold to GTCR for $400M enterprise value in 2025.
Vinod Devan is a senior technology executive and strategic operator who has built partner ecosystems and commercial organizations at the intersection of enterprise AI, SaaS, and consulting. With a career spanning Strategy&, Deloitte, Confluent (through its 2021 IPO), Globality, Cohere, and most recently Ema Unlimited as Chief Commercial Officer, Devan brings a rare combination of engineering depth, management consulting rigor, and hands-on go-to-market execution to high-growth AI companies.
Elaine Cheung is Chief Business Officer at Moonwalk Biosciences, a South San Francisco biotech backed by $57 million in funding and co-founded by CRISPR pioneer Feng Zhang and former Illumina CTO Alex Aravanis. With 20+ years navigating the inflection points of genomic medicine - from spinning GRAIL out of Illumina, helping architect its $900M+ Series B, and steering Lyell Immunopharma through its IPO - Cheung brings a rare combination of scientific literacy and deal-making precision. At Moonwalk, she is helping build the business infrastructure for a company that has pivoted from epigenetic editing to siRNA-based therapeutics targeting adipose biology and obesity.
Moriah Katherine Nachbaur is the Chief Business Officer at Pheast Therapeutics, a clinical-stage immuno-oncology company in Redwood City, California, pioneering macrophage checkpoint inhibitors to teach the immune system to destroy cancer cells. Drawing on two decades of cross-functional biopharma experience - from lab benches at Genentech to executive boardrooms at Coherus BioSciences and her own consulting firm MKN Biotech - she brings a rare blend of scientific literacy, operational depth, and strategic vision to one of oncology's most promising new frontiers: the innate immune system's untapped power against solid tumors.
Diana Peng Bockus is the Chief Executive Officer of NGM Biopharmaceuticals, a South San Francisco biotech developing first-in-class medicines for liver disease, oncology, and ophthalmology. Appointed CEO in April 2025, she joined the company in 2020 to lead business development and restructured a pivotal Merck partnership that freed NGM to build a wholly owned pipeline. A Stanford and Wharton graduate with roots in management consulting at Bain & Company, she now steers a privately held biotech backed by $515M in total funding, focused on rare diseases like primary sclerosing cholangitis and hyperemesis gravidarum.
Kathleen Forte is an Investor Relations Partner at Sequoia Capital, one of the world's most storied venture capital firms. With over two decades of experience across investor relations, business development, and fundraising, she has held senior roles at Lightspeed Venture Partners, SVB Financial Group, ADM Capital, and Clearwater Capital Partners. Known for her deep expertise in LP relationships and fund management, Forte joined Sequoia in July 2022, bringing a rare blend of financial acumen and relationship-driven dealmaking to one of Silicon Valley's most prestigious platforms.
Samantha Walter is a Healthcare Partner on the Bio + Health team at Andreessen Horowitz (a16z), where she helps portfolio companies grow by building strategic partnerships across the care delivery ecosystem - payors, providers, employers, and retail. A University of Wisconsin-Madison finance graduate originally from Minneapolis, she brings deep operational credibility to the VC world: before joining a16z, she built a Direct Contracting Entity at Carelon (then CareMore/Aspire under Anthem/Elevance) in 2020, drove customer success at Quartet Health, and cut her teeth as a healthcare revenue cycle consultant at Huron Consulting Group in New York City. She lives and works in NYC, bridging Silicon Valley capital with real-world healthcare infrastructure.